Effects of an Ankle-Foot Orthosis on Balance and Walking After Stroke: A Systematic Review and Pooled Meta-Analysis Sarah F. Tyson, FCSP, MSc, PhD, Ruth M. Kent, BMedSci, MBBS, MD, FRCP Archives of Physical Medicine and Rehabilitation Volume 94, Issue 7, Pages 1377-1385 (July 2013) DOI: 10.1016/j.apmr.2012.12.025 Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 1 Forest plot of the effects of an AFO on mobility. NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. Abbreviations: IV, inverse variance; Std., standard. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 2 Forest plot of the effects of an AFO on the time taken to negotiate a flight of stairs (s). NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. The total number of participants differs from the text, because some participants were tested with >1 type of AFO.14 Abbreviations: IV, inverse variance; Std., standard. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 3 Forest plot of the effects of an AFO on the Timed Up & Go test (s). NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. Abbreviations: IV, inverse variance; Std., standard. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 4 Forest plot of the effect of an AFO on walking speed (m/s). NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. The total number of participants differs from the text, because some participants were tested with >1 type of AFO.14,21,22 Abbreviation: IV, inverse variance. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 5 Forest plot of the effects of an AFO on weak step or stride length (m). NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. The total number of participants differs from the text, because some participants were tested with >1 type of AFO.21,22 Abbreviations: IV, inverse variance; Std., standard. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 6 Forest plot of the effects of an AFO on weight distribution. NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. Abbreviations: IV, inverse variance; Std., standard. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 7 Forest plot of the effects of an AFO on postural sway. NOTE. Because of the crossover trial design, the numbers appearing in the treatment (AFO) and control (no AFO) columns are the same participants. Abbreviations: IV, inverse variance; Std., standard. Archives of Physical Medicine and Rehabilitation 2013 94, 1377-1385DOI: (10.1016/j.apmr.2012.12.025) Copyright © 2013 American Congress of Rehabilitation Medicine Terms and Conditions